SER
SER
AMEX · Biotechnology

Serina Therapeutics Inc.

$2.37
-0.10 (-4.05%)
As of Feb 8, 2:23 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.66M 4.38M 4.18M
Net Income -1,334,716 -1,275,702 -1,196,723
EPS
Profit Margin -28.7% -29.1% -28.6%
Rev Growth -9.1% +7.3% +19.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 3.57M 3.35M 3.27M
Total Equity 11.79M 12.66M 11.81M
D/E Ratio 0.30 0.26 0.28
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,998,989 -1,970,058 -1,901,119
Free Cash Flow -1,162,960 -1,043,157 -876,007